FX.co ★ Genelux Appoints Matthew Pulisic As CFO, Stock Drops

Genelux Corporation (GNLX) revealed on Monday that it has appointed Matthew Pulisic as its Chief Financial Officer, with his tenure commencing on January 30. Pulisic brings 19 years of experience in the global biopharmaceutical industry, having most recently held the position of Vice President of Finance at Arrowhead Pharmaceuticals, a publicly listed company specializing in RNAi technology. As of today, GNLX shares are trading at $3.43 on the Nasdaq, marking a decline of 11.47 percent or $0.52.